| Patents for C12Q 1 - Measuring or testing processes involving enzymes or micro-organisms; Compositions therefor; Processes of preparing such compositions (300,231) |
|---|
| 04/28/2004 | CA2446518A1 Method of screening agents for the treatment and prevention of cancer and cachexia and the new use of specific agents for the treatment and prevention of cancer and cachexia |
| 04/27/2004 | US6728383 Method of compensating for hearing loss |
| 04/27/2004 | US6727356 Fluorescent quenching detection reagents and methods |
| 04/27/2004 | US6727354 Compositions and methods for TIGR genotyping assays |
| 04/27/2004 | US6727353 Nucleic acid encoding Kv10.1, a voltage-gated potassium channel from human brain |
| 04/27/2004 | US6727237 Alkylating 5-nitroindole with 6-bromohexyl acetate to form a 6-(N-(5-nitroindolyl)) hexyl acetate, hydrolyzing to form alcohol of above ester, estrifying with nicotinic acid, and methylating the intermediate |
| 04/27/2004 | US6727231 Effective to improve one or more of the symptoms of autistic disorder |
| 04/27/2004 | US6727225 TWEAK receptor |
| 04/27/2004 | US6727082 For identifying drugs that inhibit fungal gtpase activity, particularly those involved in cell wall integrity, hyphael formation and other functions critical to pathogenesis; isolated geranylgeranyl protein transferase |
| 04/27/2004 | US6727080 Monoclonal antibodies for use in cancer immunotherapy and their preparation; marker not restricted to previously defined histological classes of cancer |
| 04/27/2004 | US6727076 Utilizes a gel forming matrix for the rapid screening of clinical and environmental cultures |
| 04/27/2004 | US6727075 Measuring lipid peroxidation in mammals; obtain tissue or fluid sample evaluate the concentration of prostaglandin isomer marker present, compare to control, amplified concentration of the marker indicates oxidative stress |
| 04/27/2004 | US6727074 Alzheimer's disease secretase, APP substrates therefor, and uses therefor |
| 04/27/2004 | US6727071 System for cell-based screening |
| 04/27/2004 | US6727070 Protein/solubility folding assessed by structural complementation |
| 04/27/2004 | US6727068 Method for non-redundant library construction |
| 04/27/2004 | US6727067 Analysis of target non-proteinaceous components, in particular nucleic acids, using a protease which is relatively cheap, has constant quality and can be used in a variety of processes |
| 04/27/2004 | US6727066 Complementary dna; hyperlipidemia; high throughput assay/screening; medical diagnosis |
| 04/27/2004 | US6727065 Methods of use of semiconductor nanocrystal probes for treating a material |
| 04/27/2004 | US6727064 Antiinflammatory agents; anticarcinogenic agents |
| 04/27/2004 | US6727063 Single nucleotide polymorphisms in genes |
| 04/27/2004 | US6727061 Methods for identifying species or Shigella and E. coli using operon sequence analysis |
| 04/27/2004 | US6727058 Transfecting cell with first polynucleotide comprising retroviral genome operably linked to first inducible transcription regulation element wherein retroviral genome is defective for self-replication, second, third polynucleotides |
| 04/27/2004 | US6726883 Spotting pin |
| 04/27/2004 | US6726880 Device comprising support substrate, array of microlocations comprising electronically addressable electrodes, two collection electrodes adjacent to opposite sides of array, and flow cell adapted to be supported on substrate |
| 04/27/2004 | US6726847 Silver stain removal by chemical etching and sonication |
| 04/27/2004 | US6726818 Biosensors with porous chromatographic membranes |
| 04/25/2004 | CA2446871A1 Method of monitoring the menstrual cycle and/or pregnancy in a female |
| 04/24/2004 | WO2004038042A1 A 4-dimensional method and equipment of detecting nucleic acid hybrid pair on the gene chip |
| 04/24/2004 | CA2429101A1 Method and equipment to monitor nucleic acid hybridization on a dna chip using four-dimensional parameters |
| 04/22/2004 | WO2004034060A2 Isolated post-translationally modified proteins for monitoring and diagnosing muscle damage |
| 04/22/2004 | WO2004034055A2 Method for detecting and limiting breast carcinoma risk by a micronucleus test of binuclear cells |
| 04/22/2004 | WO2004034053A2 Sensor strip having a capillary flow channel with a flow terminating interface |
| 04/22/2004 | WO2004034032A2 Sliver type autonomous biosensors |
| 04/22/2004 | WO2004034027A2 Method for sizing polynucleotides using electrophoresis with non-dna size standards |
| 04/22/2004 | WO2004034025A2 Nano-chem-fet based biosensors |
| 04/22/2004 | WO2004034013A2 Genotoxicity analysis |
| 04/22/2004 | WO2004033729A1 Method of preserving biological materials |
| 04/22/2004 | WO2004033728A2 Nucleic acid amplification primers for pcr-based clonality studies |
| 04/22/2004 | WO2004033727A1 Differential display analysis of specific genes on dna microarray for the identification of tumoral transformation of prostate tissue |
| 04/22/2004 | WO2004033726A1 Detection system |
| 04/22/2004 | WO2004033725A2 Methods and means for the treatment of inflammatory disorders involving genotyping of the 5, 10- methylenetetrahydrofolate reductase (mthfr) gene |
| 04/22/2004 | WO2004033724A1 Arrays of electrodes coated with molecules and their production |
| 04/22/2004 | WO2004033723A2 Neurodegenerative disease-associated gene |
| 04/22/2004 | WO2004033722A2 Genetic profiling and healthcare management: adme (absorption, distribution, metabolism & elimination) & toxicology related genes and probes |
| 04/22/2004 | WO2004033721A2 Hybridization samples having a reduced complexity |
| 04/22/2004 | WO2004033720A2 Analytical chip for detection of 16s-rrna from clinically relevant bacteria and analytical method based thereon |
| 04/22/2004 | WO2004033718A2 Trap-tagging: a novel method for the identification and purification of rna-protein complexes |
| 04/22/2004 | WO2004033717A1 Autism gene |
| 04/22/2004 | WO2004033716A1 Examination method and examination diagnostic for periodontal disease |
| 04/22/2004 | WO2004033715A1 A method for screening for an antimicrobial polypeptide |
| 04/22/2004 | WO2004033714A1 Identification and modulation of intermediates of alcohol metabolism |
| 04/22/2004 | WO2004033713A1 Method of investigating growable level of microorganism in environment under investigation, investigation display device and investigation system |
| 04/22/2004 | WO2004033712A2 Assays for c-mannosyltransferase |
| 04/22/2004 | WO2004033711A2 Screening assay for identifying agents that modulate pak kinase or cd45 tyrosine phosphatase activity |
| 04/22/2004 | WO2004033710A2 Itgb3 gene haplotypes and atorvastatin dose effects on hdl cholesterol |
| 04/22/2004 | WO2004033709A2 Methods, probes, and kits for detecting group a streptococcus |
| 04/22/2004 | WO2004033707A2 Extraction of dna from biological samples |
| 04/22/2004 | WO2004033683A1 Method for enriching a prokaryotic dna |
| 04/22/2004 | WO2004033675A1 Flavin protein of trypanosoma cruzi, method of screening vermicide with the use of the same and diagnostic |
| 04/22/2004 | WO2004033669A2 Methods of manipulating nucleic acids |
| 04/22/2004 | WO2004033660A2 Gene expression profiling from ffpe samples |
| 04/22/2004 | WO2004033659A2 Novel tumor suppressor gene and compositions and methods for making and using the same |
| 04/22/2004 | WO2004033656A2 Gene profiling of single or multiple cells |
| 04/22/2004 | WO2004033653A2 Gene regulation with aptamer and modulator complexes for gene therapy |
| 04/22/2004 | WO2004033650A2 Diagnostic assay and related products |
| 04/22/2004 | WO2004033649A2 High throughput multiplex dna sequence amplifications |
| 04/22/2004 | WO2004033641A2 Gene expression profiling of bladder cancer |
| 04/22/2004 | WO2004033636A2 Protein modification and maintenance molecules |
| 04/22/2004 | WO2004033631A2 Nucleic acid and polypeptide sequences from lawsonia intracellularis and methods of using |
| 04/22/2004 | WO2004033629A2 Reverse transcription on microarrays |
| 04/22/2004 | WO2004033622A2 Preservation of rna and morphology in cells and tissues |
| 04/22/2004 | WO2004033621A2 System and method for determining the sizes and quantity of polynucleotides with capillary array electrophoresis |
| 04/22/2004 | WO2004033614A1 Molecule-releasing apparatus and molecule-releasing method |
| 04/22/2004 | WO2004033485A2 Nucleic acid supported protein complementation |
| 04/22/2004 | WO2004033476A1 Target detection system having a conformationally sensitive probe comprising a nucleic acid based signal transducer |
| 04/22/2004 | WO2004033397A2 Activity-based probes, and methods of their preparation and use |
| 04/22/2004 | WO2004032878A2 Compositions, organisms and methodologies employing a novel human kinase |
| 04/22/2004 | WO2004032877A2 Compositions, organisms and methodologies employing a novel human kinase |
| 04/22/2004 | WO2004032860A2 Hiv vaccine formulations |
| 04/22/2004 | WO2004032851A2 Screening and therapeutic methods relating to neurogenesis |
| 04/22/2004 | WO2004032842A2 Molecular sub-classification of kidney tumors and the discovery of new diagnostic markers |
| 04/22/2004 | WO2004032839A2 Methods and formulations comprising agonists and antagonists of nuclear hormone receptors |
| 04/22/2004 | WO2004027056A3 Methods of use for thermostable rna ligases |
| 04/22/2004 | WO2004022574A3 Improved methods for the synthesis of nucleic acids |
| 04/22/2004 | WO2004020603A3 Analyte detection |
| 04/22/2004 | WO2004019959A9 Dna repair enzymes |
| 04/22/2004 | WO2004018704A9 Point source biological agent detection system |
| 04/22/2004 | WO2004015413B1 The method and apparatus for determining the number of living cells in a test fluid |
| 04/22/2004 | WO2004011592A3 Petal-array support for use with microplates |
| 04/22/2004 | WO2004007696A3 Oligodendrocytes derived from human embryonic stem cells for remyelination and treatment of spinal cord injury |
| 04/22/2004 | WO2004005544A3 Marker genes for determining renal toxicity |
| 04/22/2004 | WO2004003222A3 Method for screening for kinase inhibitors |
| 04/22/2004 | WO2003103571A3 Flavivirus vaccines |
| 04/22/2004 | WO2003102849A9 Method for analysis of transcription variations in a set of genes |
| 04/22/2004 | WO2003099312A8 Method for determining immune system affecting compounds |
| 04/22/2004 | WO2003097879A3 Method of identifying pancreatic ductal carcinoma-specific gene using pancreatic ductal cells, method of testing for pdc using said genes, and method of screening pharmaceutical candidate compounds for treating or preventing pdc |
| 04/22/2004 | WO2003096985A3 3d structure of the tsg101 uev domain |
| 04/22/2004 | WO2003093790A3 Sensors for biomolecular detection and cell classification |
| 04/22/2004 | WO2003093499A3 Therapeutic use of selective pde10 inhibitors |